Share on StockTwits

Shares of Mylan (NASDAQ:MYL) were the target of a large growth in short interest during the month of June. As of June 13th, there was short interest totalling 28,871,066 shares, a growth of 7.9% from the May 30th total of 26,758,962 shares, American Banking & Market News reports. Based on an average daily volume of 2,542,615 shares, the short-interest ratio is currently 11.4 days. Currently, 7.8% of the shares of the company are short sold.

Several analysts have recently commented on the stock. Analysts at Leerink Swann cut their price target on shares of Mylan from $58.00 to $57.00 in a research note on Monday, May 5th. Separately, analysts at RBC Capital cut their price target on shares of Mylan from $62.00 to $60.00 in a research note on Friday, May 2nd. Finally, analysts at Citigroup Inc. upgraded shares of Mylan from a “neutral” rating to a “buy” rating in a research note on Friday, April 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $46.40.

Mylan (NASDAQ:MYL) opened at 51.63 on Monday. Mylan has a 52 week low of $30.01 and a 52 week high of $57.52. The stock has a 50-day moving average of $49.02 and a 200-day moving average of $48.05. The company has a market cap of $19.296 billion and a P/E ratio of 32.22.

Mylan Inc (NASDAQ:MYL) is a fully integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.